Opiant Pharmaceuticals Inc
(OPNT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 4,283 | 7,670 | 20,641 | 6,774 | 5,435 |
| Gross Profit | 4,283 | 7,670 | 20,641 | 6,774 | 5,435 |
| Operating Expenses | 6,005 | 6,935 | 10,046 | 5,364 | 7,263 |
| Operating Income | -1,722 | 735 | 10,595 | 1,410 | -1,828 |
| Other Income | 77 | 213 | 88 | 112 | 92 |
| Pre-tax Income | -1,646 | 947 | 10,683 | 1,521 | -1,736 |
| Income Tax | 39 | -120 | N/A | -57 | N/A |
| Net Income Continuous | -1,685 | 1,068 | 10,683 | 1,578 | -1,736 |
| Net Income | $-1,685 | $1,068 | $10,683 | $1,578 | $-1,736 |
| EPS Basic Total Ops | -0.40 | 0.29 | 2.64 | 0.39 | -0.44 |
| EPS Basic Continuous Ops | -0.40 | 0.30 | 2.64 | 0.39 | -0.44 |
| EPS Diluted Total Ops | -0.40 | 0.33 | 1.97 | 0.31 | -0.44 |
| EPS Diluted Continuous Ops | -0.40 | 0.34 | 1.97 | 0.31 | -0.44 |
| EBITDA(a) | $-1,685 | $942 | $10,620 | $1,414 | $-1,827 |